Insecticides (India) Limited (BOM:532851)
India · Delayed Price · Currency is INR 620.15
+2.80 (0.45%)
At close: Feb 12, 2026
Insecticides (India) Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Operating Revenue | 20,727 | 19,999 | 19,664 | 18,013 | 15,040 | 14,202 |
Other Revenue | 3.45 | 3.45 | 0.28 | - | - | - |
| 20,730 | 20,003 | 19,664 | 18,013 | 15,040 | 14,202 | |
Revenue Growth (YoY) | 8.33% | 1.72% | 9.16% | 19.77% | 5.90% | 4.18% |
Cost of Revenue | 14,135 | 13,775 | 14,765 | 13,933 | 11,132 | 10,724 |
Gross Profit | 6,595 | 6,228 | 4,899 | 4,080 | 3,908 | 3,479 |
Selling, General & Admin | 1,809 | 1,652 | 1,270 | 1,082 | 916.34 | 821.01 |
Other Operating Expenses | 2,481 | 2,358 | 2,003 | 1,670 | 1,268 | 1,126 |
Operating Expenses | 4,625 | 4,304 | 3,568 | 3,016 | 2,461 | 2,198 |
Operating Income | 1,970 | 1,924 | 1,331 | 1,064 | 1,446 | 1,280 |
Interest Expense | -127.09 | -48.73 | -91.98 | -112.83 | -49.76 | -39.2 |
Interest & Investment Income | 25.83 | 25.83 | 25.69 | 3.21 | 5.88 | 26.08 |
Earnings From Equity Investments | 8.03 | 5.75 | 3.1 | 2.32 | 4.07 | 4.7 |
Currency Exchange Gain (Loss) | 27.69 | 27.69 | 39.75 | -105.98 | 17.04 | 43.56 |
Other Non Operating Income (Expenses) | 18.83 | -9.54 | -9.82 | -13.59 | 2.7 | -19.67 |
EBT Excluding Unusual Items | 1,924 | 1,925 | 1,298 | 837.62 | 1,426 | 1,296 |
Gain (Loss) on Sale of Investments | 0.52 | 0.52 | 0.5 | - | - | - |
Gain (Loss) on Sale of Assets | 1.91 | 1.91 | 17.32 | -0.67 | -12.92 | -3.79 |
Other Unusual Items | 0.18 | 0.18 | 3.38 | 1.33 | 0.52 | -97.02 |
Pretax Income | 1,926 | 1,928 | 1,319 | 838.29 | 1,414 | 1,195 |
Income Tax Expense | 510.44 | 507.51 | 298.14 | 206.18 | 339.44 | 256.01 |
Net Income | 1,416 | 1,420 | 1,021 | 632.11 | 1,074 | 939.03 |
Net Income to Common | 1,416 | 1,420 | 1,021 | 632.11 | 1,074 | 939.03 |
Net Income Growth | 4.16% | 39.13% | 61.48% | -41.16% | 14.40% | 8.04% |
Shares Outstanding (Basic) | 29 | 29 | 30 | 30 | 30 | 31 |
Shares Outstanding (Diluted) | 29 | 29 | 30 | 30 | 30 | 31 |
Shares Change (YoY) | -1.32% | -0.82% | - | -0.34% | -4.21% | - |
EPS (Basic) | 48.67 | 48.38 | 34.49 | 21.36 | 36.17 | 30.29 |
EPS (Diluted) | 48.66 | 48.38 | 34.49 | 21.36 | 36.17 | 30.29 |
EPS Growth | 5.54% | 40.28% | 61.48% | -40.96% | 19.43% | 8.04% |
Free Cash Flow | - | 561.68 | 1,379 | -980.91 | 675.7 | 1,071 |
Free Cash Flow Per Share | - | 19.14 | 46.61 | -33.14 | 22.75 | 34.53 |
Dividend Per Share | 2.000 | 2.000 | 3.000 | 3.000 | 2.000 | 1.333 |
Dividend Growth | - | -33.33% | - | 50.00% | 50.00% | -50.00% |
Gross Margin | 31.81% | 31.14% | 24.92% | 22.65% | 25.98% | 24.49% |
Operating Margin | 9.50% | 9.62% | 6.77% | 5.91% | 9.62% | 9.01% |
Profit Margin | 6.83% | 7.10% | 5.19% | 3.51% | 7.14% | 6.61% |
Free Cash Flow Margin | - | 2.81% | 7.02% | -5.45% | 4.49% | 7.54% |
EBITDA | 2,231 | 2,187 | 1,598 | 1,302 | 1,687 | 1,503 |
EBITDA Margin | 10.76% | 10.93% | 8.13% | 7.22% | 11.21% | 10.58% |
D&A For EBITDA | 260.29 | 263.11 | 266.87 | 237.03 | 240.32 | 222.44 |
EBIT | 1,970 | 1,924 | 1,331 | 1,064 | 1,446 | 1,280 |
EBIT Margin | 9.50% | 9.62% | 6.77% | 5.91% | 9.62% | 9.01% |
Effective Tax Rate | 26.50% | 26.33% | 22.61% | 24.59% | 24.01% | 21.42% |
Revenue as Reported | 20,825 | 20,069 | 19,758 | 18,026 | 15,082 | 14,280 |
Advertising Expenses | - | 258.07 | 90.13 | 94.23 | 46.74 | 52.52 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.